Abstract
There is compelling evidence for increased neovascularization of blood vessel walls at sites of intimal hyperplasia in models of arterial stenting, angioplasty, and venous bypass graft failure. We have shown that activation of the P2Y2 nucleotide receptor (P2Y2R) in vascular endothelial cells in vitro induces VCAM-1 (vascular cell adhesion molecule-1) expression and promotes the adherence of monocytes. VEGF, a pleiotropic factor that regulates endothelial cell survival, proliferation, and migration through its interaction with two receptor tyrosine kinases, Flt-1 or VEGF receptor-1 and Flk-1/KDR or VEGF receptor-2 also stimulates the expression of VCAM-1 in endothelial cells. Interestingly, our studies indicate that P2Y2R activation promotes the VEGF-independent activation of Flk-1/KDR via Src binding to Src homology (SH3) binding domains in the C-terminal tail of the P2Y2R leading to the up-regulation of VCAM-1. The P2Y2R also contains an arginine-glycine-aspartate domain that mediates interactions with αvβ3/β5 integrins that enable nucleotides to increase cell migration, an important event in inflammation and tumor angiogenesis. Taken together, these findings indicate that P2Y2Rs can stimulate multiple signaling pathways to promote a variety of pathological responses underlying chronic inflammation, angiogenesis in tumors and atherosclerosis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Agca C, Seye C, Kashuba Benson CM, Rikka S, Chan AW, Weisman GA, Agca Y. (2009) Development of a Novel Transgenic Rat Overexpressing the P2Y2 Nucleotide Receptor Using a Lentiviral Vector. J Vasc Res 46:447–58.
Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF. (2000) Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J Neurochem 74:1951–60.
Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW. (2002) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann N Y Acad Sci 977:45–64.
Armulik A, Abramsson A, Betsholtz C. (2005) Endothelial/pericyte interactions. Circ Res 97:512–23.
Bagchi S, Liao Z, Gonzalez FA, Chorna NE, Seye CI, Weisman GA, Erb L. (2005) The P2Y2 nucleotide receptor interacts with αv integrins to activate Go and induce cell migration. J Biol Chem 280:39050–7.
Baker OJ, Camden JM, Rome DE, Seye CI, Weisman GA. (2008) P2Y2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol 45:65–75.
Barger AC, Beeuwkes R, 3rd, Lainey LL, Silverman KJ. (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 310:175–7.
Beekhuizen H, van Furth R. (1993) Monocyte adherence to human vascular endothelium. J Leukoc Biol 54:363–78.
Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF. (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54:832–7.
Bergfeld GR, Forrester T. (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40–7.
Boarder MR, Hourani SM. (1998) The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 19:99–107.
Bodin P, Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem Res 26:959–69.
Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR. (1994) Osteopontin expression and distribution in human carcinomas. Am J Pathol 145:610–23.
Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P, Gadeau AP. (2001) Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 89:772–8.
Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, Caciagli F, Rathbone MP. (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25:93–8.
Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. (2000) Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors. Cell Signal 12:351–60.
De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, Jr., Shin WS, Liao JK. (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60–8.
Di Virgilio F, Solini A. (2002) P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 135:831–42.
Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, Lamaziere JM, Bonnet J. (1998) Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 18:168–76.
Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS, 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010–7.
Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC, Griffin K, Neal C, Krugh B, Santiago-Perez LI, Gonzalez FA, Gresham HD, Turner JT, Weisman GA. (2001) An RGD sequence in the P2Y2 receptor interacts with αVβ3 integrins and is required for Go-mediated signal transduction. J Cell Biol 153:491–501.
Erlinge D, Yoo H, Edvinsson L, Reis DJ, Wahlestedt C. (1993) Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol 265:H1089–97.
Erlinge D, You J, Wahlestedt C, Edvinsson L. (1995) Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur J Pharmacol 289:135–49.
Esmon CT, Taylor FB, Jr., Snow TR. (1991) Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 66:160–5.
Folkman J. (1985) Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med 29:10–36.
Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. (1993) Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13:120–5.
Geiringer E. (1951) Intimal vascularization and atherosclerosis. J Pathol Bacteriol 63:201–11.
Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR. (2002) Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 277:44638–50.
Giri R, Selvaraj S, Miller CA, Hofman F, Yan SD, Stern D, Zlokovic BV, Kalra VK. (2002) Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am J Physiol Cell Physiol 283:C895–904.
Giri R, Shen Y, Stins M, Du Yan S, Schmidt AM, Stern D, Kim KS, Zlokovic B, Kalra VK. (2000) Beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol 279:C1772–81.
Goepfert C, Sundberg C, Sevigny J, Enjyoji K, Hoshi T, Csizmadia E, Robson S. (2001) Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104:3109–15.
Grierson JP, Meldolesi J. (1995) Shear stress-induced [Ca2+]i transients and oscillations in mouse fibroblasts are mediated by endogenously released ATP. J Biol Chem 270:4451–6.
Hayden MR, Tyagi SC. (1998) Arterial vascular remodeling: the endothelial cell’s central role. Mol Med 95:213–7.
Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047–55.
Hirschi KK, D’Amore PA. (1996) Pericytes in the microvasculature. Cardiovasc Res 32:687–98.
Hirschi KK, Rohovsky SA, D’Amore PA. (1998) PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:805–14.
Hodivala-Dilke KM, Reynolds AR, Reynolds LE. (2003) Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res 314:131–44.
Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S. (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21:1975–82.
Hynes RO. (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11–25.
Jackson SW, Hoshi T, Wu Y, Sun X, Enjyoji K, Cszimadia E, Sundberg C, Robson SC. (2007) Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Am J Pathol 171:1395–404.
Kaczmarek E, Erb L, Koziak K, Jarzyna R, Wink MR, Guckelberger O, Blusztajn JK, Trinkaus-Randall V, Weisman GA, Robson SC. (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93:735–42.
Kahlon R, Shapero J, Gotlieb AI. (1992) Angiogenesis in atherosclerosis. Can J Cardiol 8:60–4.
Kaiser RA, Oxhorn BC, Andrews G, Buxton IL. (2002) Functional compartmentation of endothelial P2Y receptor signaling. Circ Res 91:292–9.
Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614–20.
Kong Q, Peterson TS, Baker O, Stanley E, Camden J, Seye CI, Erb L, Simonyi A, Wood WG, Sun GY, Weisman GA. (2009) Interleukin-1β enhances nucleotide-induced and α-secretase-dependent amyloid precursor protein processing in rat primary cortical neurons via up-regulation of the P2Y2 receptor. J Neurochem 109:1300–10.
Koster W. (1876) Endarteritis and arteritis. Berl Klin Wochenschr 13:454–55.
Liao Z, Seye CI, Weisman GA, Erb L. (2007) The P2Y2 nucleotide receptor requires interaction with αv integrins to access and activate G12. J Cell Sci 120:1654–62.
Lindahl P, Hellstrom M, Kalen M, Betsholtz C. (1998) Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. Curr Opin Lipidol 9:407–11.
Lindahl P, Johansson BR, Leveen P, Betsholtz C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242–5.
Liu J, Liao Z, Camden J, Griffin KD, Garrad RC, Santiago-Perez LI, Gonzalez FA, Seye CI, Weisman GA, Erb L. (2004) Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 279:8212–8.
Lustig KD, Erb L, Landis DM, Hicks-Taylor CS, Zhang X, Sportiello MG, Weisman GA. (1992) Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochim Biophys Acta 1134:61–72.
Malam-Souley R, Campan M, Gadeau AP, Desgranges C. (1993) Exogenous ATP induces a limited cell cycle progression of arterial smooth muscle cells. Am J Physiol 264:C783–8.
Marcus AJ, Safier LB. (1993) Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 7:516–22.
Marx J. (2003) Cell biology. How cells step out. Science 302:214–6.
Neary JT, Baker L, Jorgensen SL, Norenberg MD. (1994) Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol 87:8–13.
Neary JT, Whittemore SR, Zhu Q, Norenberg MD. (1994) Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J Neurochem 63:490–4.
North RA, Surprenant A. (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563–80.
Parker AL, Likar LL, Dawicki DD, Rounds S. (1996) Mechanism of ATP-induced leukocyte adherence to cultured pulmonary artery endothelial cells. Am J Physiol 270:L695–703.
Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L, Weisman GA, Boucher RC, Turner JT. (1994) Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91:3275–9.
Pearson JD, Gordon JL. (1979) Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281:384–6.
Pedersen S, Pedersen SF, Nilius B, Lambert IH, Hoffmann EK. (1999) Mechanical stress induces release of ATP from Ehrlich ascites tumor cells. Biochim Biophys Acta 1416:271–84.
Pillois X, Chaulet H, Belloc I, Dupuch F, Desgranges C, Gadeau AP. (2002) Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ Res 90:678–81.
Ralevic V, Burnstock G. (1991) Roles of P2-purinoceptors in the cardiovascular system. Circulation 84:1–14.
Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C, Gadeau AP. (2003) AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ Res 93:674–81.
Renault MA, Jalvy S, Potier M, Belloc I, Genot E, Dekker LV, Desgranges C, Gadeau AP. (2005) UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem 280:2708–13.
Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185:153–63.
Ross R. (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57:791–804.
Rumjahn SM, Javed MA, Wong N, Law WE, Buxton IL. (2007) Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase. Br J Cancer 97:1372–80.
Satterwhite CM, Farrelly AM, Bradley ME. (1999) Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am J Physiol 276:H1091–7.
Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C, Scalbert E, Chardin P, Pacaud P, Loirand G. (2000) P2Y1, P2Y2, P2Y4, and P2Y6 receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278:H1751–61.
Senger DR, Perruzzi CA, Papadopoulos A. (1989) Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 9:1291–9.
Seye CI, Gadeau AP, Daret D, Dupuch F, Alzieu P, Capron L, Desgranges C. (1997) Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 17:3602–10.
Seye CI, Kong Q, Erb L, Garrad RC, Krugh B, Wang M, Turner JT, Sturek M, Gonzalez FA, Weisman GA. (2002) Functional P2Y2 nucleotide receptors mediate uridine 5艂-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106:2720–6.
Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA. (2004) The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279:35679–86.
Seye CI, Yu N, Jain R, Kong Q, Minor T, Newton J, Erb L, Gonzalez FA, Weisman GA. (2003) The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278:24960–5.
Shen BQ, Lee DY, Zioncheck TF. (1999) Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem 274:33057–63.
Shen J, Seye CI, Wang M, Weisman GA, Wilden PA, Sturek M. (2004) Cloning, up-regulation, and mitogenic role of porcine P2Y2 receptor in coronary artery smooth muscle cells. Mol Pharmacol 66:1265–74.
Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, Chambers AF, Harris JF. (1997) Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 3:605–11.
Takahashi F, Akutagawa S, Fukumoto H, Tsukiyama S, Ohe Y, Takahashi K, Fukuchi Y, Saijo N, Nishio K. (2002) Osteopontin induces angiogenesis of murine neuroblastoma cells in mice. Int J Cancer 98:707–12.
Tallquist MD, French WJ, Soriano P. (2003) Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol 1:288–99.
Tanimoto T, Jin ZG, Berk BC. (2002) Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277:42997–3001.
Tenaglia AN, Peters KG, Sketch MH, Jr, Annex BH. (1998) Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am Heart J 135:10–4.
Thuringer D, Maulon L, Frelin C. (2002) Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells. J Biol Chem 277:2028–32.
Townsend KP, Obregon D, Quadros A, Patel N, Volmar C, Paris D, Mullan M. (2002) Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci 977:65–76.
Ventura MA, Thomopoulos P. (1995) ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3. Mol Pharmacol 47:104–14.
Wang DJ, Huang NN, Heppel LA. (1992) Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 153:221–33.
Wang M, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA. (2005) P2Y2 nucleotide receptor interaction with αv integrin mediates astrocyte migration. J Neurochem 95:630–40.
Weisman GA, Yu N, Liao Z, Gonzalez F, Erb L, Seye CI. (2006) P2 receptors in health and disease. Biotechnol Genet Eng Rev 22:171–95.
Weller RO, Yow HY, Preston SD, Mazanti I, Nicoll JA. (2002) Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer’s disease. Ann N Y Acad Sci 977:162–8.
Yang S, Buxton IL, Probert CB, Talbot JN, Bradley ME. (1996) Evidence for a discrete UTP receptor in cardiac endothelial cells. Br J Pharmacol 117:1572–8.
Zeng H, Sanyal S, Mukhopadhyay D. (2001) Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. J Biol Chem 276:32714–9.
Zimmermann H, Braun N. (1996) Extracellular metabolism of nucleotides in the nervous system. J Auton Pharmacol 16:397–400.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Seye, C.I., Weisman, G.A. (2010). The P2Y2 Nucleotide Receptor in Vascular Inflammation and Angiogenesis. In: Gerasimovskaya, E., Kaczmarek, E. (eds) Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3435-9_4
Download citation
DOI: https://doi.org/10.1007/978-90-481-3435-9_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3434-2
Online ISBN: 978-90-481-3435-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)